Mrs. Mirka Normand, OTR, MA, CHT, COMT Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 52 Hazelnut Hill Rd, Groton, CT 06340 Phone: 860-446-8265 Fax: 860-445-2076 |
Stephanie Law, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-9960 |
Julie Hill Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 428 Long Hill Rd, Groton, CT 06340 Phone: 917-279-0906 Fax: 203-286-1688 |
Jessica E Vincent, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 235 Lestertown Rd, Groton, CT 06340 Phone: 860-445-7478 |
Mariana Tamayo Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-9960 |
Mrs. Julia Gwen Rice, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-9960 |
Mrs. Jane Sinclair Manaras, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-3135 |
Patricia Thomas Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-9960 |
Brenda Hultgren, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 425 Drozdyk Dr, Groton, CT 06340 Phone: 860-446-2889 |
Holly-ann Hoff, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 36 Maple Dr, Groton, CT 06340 Phone: 716-440-5252 |
Ms. Lauren Anne Dessereaux, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Peqout Health Center, 52 Hazelnut Hill Road, Groton, CT 06340 Phone: 260-446-8265 |
Faye Rose Erwin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-9960 |
Meghan Daniels Cook, OTR/L Occupational Therapist - Physical Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-3134 |
Jennifer Lombardo, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 52 Hazelnut Hill Rd, Groton, CT 06340 Phone: 860-446-8265 |
Amanda Kathleen Dobyns, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 337-281-8161 |
Catherine Canavan, MS OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton Regency, Groton, CT 06340 Phone: 860-446-9960 Fax: 860-449-0289 |
Mr. Paul S. Goldstein, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 52 Hazelnut Hill Rd, Groton, CT 06340 Phone: 860-446-8265 |
Maura Wainio, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 52 Hazelnut Hill Rd, Groton, CT 06340 Phone: 860-446-8265 Fax: 860-445-2076 |
Ms. Emily Louise Amaral, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1145 Poquonnock Rd, Groton, CT 06340 Phone: 860-446-9960 |
News Archive
Zymeworks Inc. today announced a research collaboration with Merck, known as MSD outside the United States and Canada, around Zymeworks' proprietary Azymetric platform for the development of novel bi-specific antibody therapeutic candidates. Bi-specific antibodies are designed to bind to two different drug targets for broad use in clinical applications such as oncology or autoimmune disease.
In addition, diabetic women in the study who also had kidney disease or obesity, or whose diabetes was poorly controlled (fasting blood sugar levels above 300 mg/dL) had a risk of heart failure 6-10 times higher than that of women without diabetes.
Future technology may be able to monitor and modify the brain to produce enhanced team performance, while increasing the efficiency and accuracy of decisions.
The diabetes drug sitagliptin appears to reduce the severity of reactive hypoglycemia, a form of low blood sugar that occurs after a meal, a preliminary study finds. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston.
VIVUS, Inc. today announced that the company, as part of its continuing effort to secure regulatory approval for QNEXA® in the U.S., submitted a briefing document to the Food and Drug Administration (FDA) designed to address items in the FDA's Complete Response Letter (CRL), issued on October 28, 2010. The company also announced that the Endocrine and Metabolic Division of the FDA has granted VIVUS a meeting in the second half of January 2011 to discuss the content of the proposed resubmission.
› Verified 3 days ago